GlassScriptPhysician profile
Matthew L Voth
NPI 1871759530
$1,502.18
in general payments reported to CMS, 2019-2025
10 companies · $823 in 2025
The $823 reported for 2025 was more than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $165 · 2020: $96.69 · 2024: $417 · 2025: $823.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,241.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,240.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $202.25 | 2024 | Hemosphere |
| Innovation Technologies INC | $171.05 | 2019-2024 | Irrisept |
| Aroa Biosurgery Incorporated | $167.05 | 2025 | |
| Thd America, INC. | $161.51 | 2024 | |
| Ethicon US, LLC | $158.82 | 2025 | Echelon Flex, Smartablatetm System Rf Generator |
| Baxter Healthcare | $148.40 | 2025 | Perclot |
| Covidien LP | $143.89 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $119.94 | 2025 | Exparel |
| Intuitive Surgical, INC. | $119.44 | 2025 | |
| Vertex Pharmaceuticals Incorporated | $109.83 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Voth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.